Traders should monitor for future 8-Ks indicating actual drawdowns under this facility, which would signal immediate dilution. Absent such filings, this is a standby financing tool with minimal near-term impact. Watch for downward pressure on share price if draws occur during weak market conditions.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 17 $0.7500entry
- T+1 · 7mo ago +1.33%α +1.52% · $0.7600
- T+5 · 7mo ago −4.00%α −4.55% · $0.7200
- T+20 · 6mo ago −13.33%α −18.70% · $0.6500
- T+60 · 4mo ago −26.67%α −32.81% · $0.5500
Price Chart
How similar events traded
Executive Summary
Vaxart announced a $25 million at-the-market equity financing facility with Lincoln Park Capital, allowing the company to sell shares at its discretion over 24 months. The agreement provides non-dilutive flexibility but does not guarantee any funding, as Vaxart controls the timing and amount of sales.
Key Financial Metrics
Key Facts
- Vaxart entered into a share purchase agreement (SPA) with Lincoln Park Capital Fund for up to $25 million in common stock sales over 24 months.
- Vaxart has sole discretion over the timing and amount of sales; Lincoln Park is obligated to buy at prevailing market prices with no price cap.
- No warrants, rights, or short-selling by Lincoln Park are permitted.
- A registration statement must be declared effective by the SEC before any sales can occur.
- The company issued shares to Lincoln Park as commitment consideration, though the amount is not disclosed.
Financial Impact
Up to $25 million in potential gross proceeds, subject to market conditions and Vaxart's discretion.
Risk Factors
- Potential share dilution if Vaxart draws significantly on the facility, especially in a declining stock price environment.
- Market perception of equity lines as a 'last resort' financing could negatively impact sentiment despite no immediate dilution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3276132 |
Track record
23 reports on VXRT
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +37.66% at T+60 after the May 1, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $0.3700 Now $0.3600 +2.70% settles Feb 4
- Oct 19, 202628d ago 8-K Neutral 3/10 Entry $0.4900 Now $0.3600 −26.53% settles Jan 15
- Jul 28, 202615w ago 8-K Neutral 2/10 Entry $0.4800 to $0.4900 Now $0.3600 −25.00% ▲ +2.08% −2.53% vs SPY
- Jul 7, 202618w ago 8-K Neutral 4/10 Entry $0.5500 to $0.4500 Now $0.3600 −34.55% ▼ −18.18% −21.27% vs SPY
- Jul 6, 202619w ago DEFA14A Neutral 5/10 Entry $0.6200 to $0.4540 Now $0.3600 −41.94% ▼ −26.77% −28.93% vs SPY
- Jul 2, 202619w ago DEFA14A Bullish 5/10 Entry $0.6400 to $0.4500 Now $0.3600 −43.75% ▼ −29.69% −33.51% vs SPY
- Jul 2, 202619w ago 8-K Neutral 4/10 Entry $0.6400 to $0.4520 Now $0.3600 −43.75% ▼ −29.38% −32.80% vs SPY
- Jun 26, 202620w ago DEFA14A Neutral 4/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
- Jun 26, 202620w ago DEFA14A Neutral 3/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
- Jun 26, 202620w ago 8-K Mixed 5/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers